0D1W
vs
D
DAX Index
0D1W
Over the past 12 months, 0D1W has underperformed DAX Index, delivering a return of -91% compared to the DAX Index's +10% growth.
Stocks Performance
0D1W vs DAX Index
Performance Gap
0D1W vs DAX Index
Performance By Year
0D1W vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Biophytis SA
Glance View
Biophytis SA is a holding company. The company is headquartered in Paris, Ile-De-France and currently employs 24 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.